Form 8-K - Current report:
SEC Accession No. 0001477932-26-000055
Filing Date
2026-01-07
Accepted
2026-01-07 09:28:37
Documents
15
Period of Report
2026-01-06
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aspi_8k.htm   iXBRL 8-K 39244
2 PRESS RELEASE aspi_ex992.htm EX-99.2 17776
  Complete submission text file 0001477932-26-000055.txt   185161

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aspi-20260106.xsd EX-101.SCH 5022
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE aspi-20260106_lab.xml EX-101.LAB 15213
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aspi-20260106_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aspi-20260106_pre.xml EX-101.PRE 9640
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aspi-20260106_def.xml EX-101.DEF 2099
17 EXTRACTED XBRL INSTANCE DOCUMENT aspi_8k_htm.xml XML 3534
Mailing Address 2200 ROSS AVENUE, SUITE 4575E DALLAS TX 75201
Business Address 2200 ROSS AVENUE, SUITE 4575E DALLAS TX 75201 202-756-2245
ASP Isotopes Inc. (Filer) CIK: 0001921865 (see all company filings)

EIN.: 872618235 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41555 | Film No.: 26514259
SIC: 2890 Miscellaneous Chemical Products
(CF Office: 08 Industrial Applications and Services)